Accounts Payable: Creating Competitive Advantage

Most people view the Accounts Payable (AP) department as a function within the Procure to Pay process that is necessary but unlikely to create a competitive advantage. However, a company can transform the traditional AP cost center into a cost savings driver. It can do this by employing a simple strategy that consists of analytical tools, robust processes, and a team approach to drive outstanding results. This paper outlines how we forged this transformation at Baptist Health.

CQO Tie-in: Transforming the Accounts Payable function into a cost savings driver is a perfect example of the intersection of Cost, Quality, and Outcomes. Reducing manual labor impacts labor costs directly, and indirectly impacts the ability to negotiate more favorable costs based upon faster payment to supply partners. With credit holds virtually eliminated, quality of care and patient outcomes are no longer threatened by suppliers withholding procedural supplies for payment. And ultimately, suppliers want to do business with healthcare organizations that can support their cash flow through on-time payments. Having a solid reputation among suppliers ensures the most innovative products in the market will be available to provide the highest quality patient care.

Download White Paper

Related Resources

Webcast
Howard Mann, vice president, supply chain management at Cardiovascular Care Group discusses the basics of value analysis and value based purchasing
Webcast
The intersection of CQO is patient care, Deborah Rey presents ten commandments you should adopt if they're not already part of your values both…
On-Demand Educational Webinars
The engagement and alignment of employees accelerates achievement of quality, safety, service and operational goals. These tasks are easily stated…
Book
Presenting the core concepts and techniques of supply chain management in a clear, concise, and easily readable style, the Third Edition
Podcasts
AHRMM Podcast on how supply chain should be interdepartmentally conversing to determine the handling of human-origin medical products and their UDIs.